Role of Mosapride in Patients With Gastroesophageal Reflux Disease

NCT00729339 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: mosapride for the first month and placebo for the 2nd month
DRUG: placebo for the first and mosapride for the second month

Sponsor

Lotung Poh-Ai Hospital

Collaborators

[object Object]